MMP2 and neoplasm: Because some effective antitumor agents targeting tumor vessel formation have been shown to reduce MMP2 activity [29,30] and MMP2 produced by endothelial cells is known to contribute to the progress of angiogenesis [17], we investigated MMP2 enzyme activity in response to EEGS treatment.